YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure in the Inpatient Setting

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Other: Best practice alert for the notification of patient HFrEF and recommended evidence-based medical therapies (NO drugs are being administered in this trial)

First Posted Date: 2020-12-29

Last Posted Date: 2024-01-26

Lead Sponsor: Yale University

Target Recruit Count: 1012

Registration Number: NCT04686604

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

CYstic Fibrosis bacterioPHage Study at Yale (CYPHY)

Phase 1

Completed

Conditions: Cystic Fibrosis

Interventions: Other: Placebo
Drug: Standard Dose YPT-01

First Posted Date: 2020-12-24

Last Posted Date: 2023-11-18

Lead Sponsor: Yale University

Target Recruit Count: 8

Registration Number: NCT04684641

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Assessment, Feedback, Incentive, Exchange (AFIX OB) A Customizable Quality Improvement Intervention to Increase Maternal Vaccine Uptake

Not Applicable

Completed

Conditions: Influenza
Whooping Cough

Interventions: Behavioral: AFIX-OB Quality Improvement Package

First Posted Date: 2020-12-21

Last Posted Date: 2023-09-21

Lead Sponsor: Yale University

Target Recruit Count: 202

Registration Number: NCT04678271

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Weight Regain Treatment Post-Bariatric Surgery

Phase 2

Completed

Conditions: Obesity, Overweight

Interventions: Behavioral: Behavioral Weight Loss (BWL)

First Posted Date: 2020-12-10

Last Posted Date: 2023-11-13

Lead Sponsor: Yale University

Target Recruit Count: 26

Registration Number: NCT04662801

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care

Recruiting

Conditions: Congenital Uterine Anomaly

First Posted Date: 2020-12-09

Last Posted Date: 2024-04-11

Lead Sponsor: Yale University

Target Recruit Count: 300

Registration Number: NCT04661072

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

AB154 Combined With AB122 for Recurrent Glioblastoma

Early Phase 1

Active, not recruiting

Conditions: Glioblastoma

Interventions: Drug: Zimberelimab
Drug: Domvanalimab
Drug: Placebo

First Posted Date: 2020-12-07

Last Posted Date: 2025-04-04

Lead Sponsor: Yale University

Target Recruit Count: 46

Registration Number: NCT04656535

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

Behavior Therapy for Irritability in Autism

Not Applicable

Recruiting

Conditions: Anger
Irritability
Autism Spectrum Disorder
Disruptive Behavior
Asperger Syndrome
Pervasive Developmental Disorder
Aggression

Interventions: Behavioral: Behavioral Therapy for Irritability in Autism
Behavioral: Psychoeducation and Supportive Therapy (PST)

First Posted Date: 2020-12-04

Last Posted Date: 2025-05-16

Lead Sponsor: Yale University

Target Recruit Count: 126

Registration Number: NCT04654260

Locations: 🇺🇸
Yale Child Study Center, New Haven, Connecticut, United States

Outcomes After Albumin vs Lactated Ringer's Solution in CABG and AVR Procedures

Not Applicable

Recruiting

Conditions: Coronary Artery Bypass Graft Surgery
Aortic Valve Replacement

Interventions: Other: Lactated Ringer's Solution
Other: Albumin Solution

First Posted Date: 2020-12-03

Last Posted Date: 2024-06-27

Lead Sponsor: Yale University

Target Recruit Count: 400

Registration Number: NCT04652375

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Feasibility, Acceptability, and Barriers to Implementation of a Geriatrics Bundle in the ICU

Not Applicable

Completed

Conditions: Intensive Care Unit Syndrome

Interventions: Other: Geriatrics Bundle

First Posted Date: 2020-12-03

Last Posted Date: 2024-02-16

Lead Sponsor: Yale University

Target Recruit Count: 83

Registration Number: NCT04652453

Locations: 🇺🇸
Yale-New Haven Hospital, New Haven, Connecticut, United States

Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3

Phase 4

Recruiting

Conditions: Heart Failure

Interventions: Drug: LCZ 696
Drug: Placebo
Drug: Para-aminohippurate
Drug: Iohexol
Drug: Aprepitant

First Posted Date: 2020-12-02

Last Posted Date: 2024-03-05

Lead Sponsor: Yale University

Target Recruit Count: 80

Registration Number: NCT04649229

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy